ARE YOU A HEALTHCARE PROFESSIONAL?

Please note you are entering now content intended only for Healthcare Professionals.

The World's First and Only Sinusoidal Trifocal IOL

Acrivaᵁᴰ Trinova™ is the next-generation sinusoidal trifocal IOL designed with stepless zones. Twelve unique ridges create the highest light transmission and optimum light distribution through all optical diameters.

Sinusoidal Vision Technology is inspired by the sinusoidal pattern seen in nature. We created trifocality with the help of Sinusoidal Vision Technology that displays Sine wave like surface pro­le. This revolutionary patented technology is designed to obtain the best optical performance from an IOL. More light transmission, optimum light distribution, less scattered light, less halo&glare, real continuous vision...

Get Rid Of The Sharp Edges

Sharp edges and pointy peaks of the overlapping pattern on the traditional trifocal IOLs are the main causes of positive dysphotopsia. Acrivaᵁᴰ Trinova® has smoothly varying surface profile that helps to reduce halos and glare due to reduced scattered light

What is Sinusoidal Vision Technology (SVT®)?

AcrivaUD Trinova® is manufactured with Sinusoidal Vision Technology (SVT). The SVT is a unique patented technique for producing an IOL optical surface that does not exhibit any sharp edges. It provides the best optical performance in trifocal IOL design. The lens shape is derived from sinusoidal functions and results in smoothly varying surface profiles. Therefore, ideal continuous vision is achieved, as opposed to common traditional overlapping diffraction pattern trifocal IOLs with sharp edges. This concept also helps to reduce halos and scattered light.

Benefits of Sinusoidal Vision Technology (SVT®)?

Tolerance on
• Biometry measurement deviation (±0,75 D post-op refractive suprises)
• Slight post-op tilts
• Higher kappa angle
Minimized dysphotopsia due to the reduced scattered light

Superior Features of Acrivaᵁᴰ Trinova®

• 92% effective light transmission to retina
• Widest depth of focus
• Excellent MTF results at all distances
• Outstanding visual outcomes in mesopic conditions

Maximum Light Transmission to Retina

It is known that overlapping diffractive pattern trifocal IOLs cause significant light loss. Each one percentage of light loss affects patients’ overall visual performance exponentially. Acrivaᵁᴰ Trinova™ ensures maximum light transfer, thanks to its stepless diffractive zones. The higher the light transmission, the better the contrast sensitivity!

Comfortable Reading Distances

+3.00D near addition and +1.50D intermediate addition of Acrivaᵁᴰ Trinova™ is precisely designed with life quality of the patient in mind. Up to 80 cm reading distance will cover all daily requirements in near and intermediate vision. See the comparison table below.6,7,8

Balanced Light Distribution

Light distribution plays a big role in obtaining seamless, continuous vision. Conventional trifocal IOL designs distribute light energy in a ratio such that zones of discontinuity may be noticeable to patients. AcrivaUD TrinovaTM incorporates a unique sinusoidal surface profile with twelve smooth ridges, providing a more continuous light-energy distribution. This leads to remarkable spectacle-free visual competencies not only in photopic, but also in mesopic conditions.6

Premium Material

Best of Both Worlds!

Excellent material combination of 2-Oxiethylmethacrylate and 2-Hydroxymethacrylate monomers create hydrophobic surface behavior with the advantage of hydrophilic flexibility.

All Acriva product lines are made with the same Premium Material and Biomechanics.

Proven Hydrophobic Surface Behavior

AcrivaUD TrinovaTM has similar contact angle measurements similar to pure hydrophobic IOLs. An independent comparative study showed that the hydrophobic surface of AcrivaUD TrinovaTM is similar to that of pure hydrophobic competitors.

Benefits of Hydrophobic and Hydrophilic Monomers

  • No glistening
  • No calcification
  • Low inflammatory response
  • Limited PCO
  • Easy to fold and inject
  • Quickly unfolding in the eye
  • High biocompatibility
  • MICS capability

Better Flexibility

The elastic co-polymer of AcrivaUD TrinovaTM has precise memory. Point Spread Function (PSF) shows that the optic quickly recovers its initial shape within one hour, much quicker than hydrophobic IOLs.

Light Filtration – Efficient Photoprotection

OPTIMUM FILTRATION RANGE – BALANCED PHOTOPROTECTION OF UVA AND VIOLET SPECTRUM

AcrivaUD Trinova is a member of the AcrivaUD BB family and it provides excellent photoprotection from potential damage of the UVA and violet spectrum without blocking blue light. AcrivaUD BB ensures 95% blue light transmission at 480 nm which is known as critical in controlling the circadian rhythm

The chromophore used in AcrivaUD BB material is the same chromophore as in the human natural lens which gives similar transmission structure as a young human lens.

Biomechanics

360° All Square Enhanced Edge

Real PCO Barrier

The innovative edge design tends to greatly reduce PCO risk by forming a geometric and mechanical barrier against cells proliferation. The edge design produces thinner lenses for equivalent power than competitors.

Exceptional Design

360° All Enhanced Square Edge and premium material form a dual barrier against the risk of posterior capsule opacification after implantation. Recent studies have shown that square edge on posterior surface of the optic is the most important IOL-related factor against PCO.

All Models

Pro Version

AcrivaUD Trinova Pro C Pupil Adaptive®

Toric Version

Acrivaᵁᴰ Trinova Toric

References:

1. Data on file.

2. Data on file

3. Gatinel D, Pagnoulle C, Houbrechts Y, Gobin L. Design and qualification of a diffractive trifocal optical profile for intraocular lenses. J Cataract Refract Surg. 2011;37(11):2060-2067.

4. Mojzis P, Pena-García p, Liehneova I, Ziak P, Alio J L. Outcomes of a new diffractive trifocal intraocular lens. J Cataract Refract Surg. 2014; 40:60-69.

5. Lee S, Choi M, Xu Z, Zhao Z, Alexander E, Liu Y. Optical bench performance of a novel trifocal intraocular lens compared with a multifocal intraocular lens. Clinical Ophthalmology (Auckland, NZ). 2016; 10:1031-1038. doi:10.2147/OPTH.S106646.

6. Data on file.

7. E.Law R. Aggarwal, H. Kasaby. Comparison of a bifocal and a trifocal intraocular lens. Free Paper Session ESRCS 2014 London.

8. K.Gundersen. Diffractive multifocal IOLs: a comparative study of Finevision versus ReSTOR 2.5 and 3.0D. Free Paper Session ESRCS 2014

9. Data on file.

10. Law EM, Aggarwal RK, Kasaby H. Clinical outcomes with a new trifocal intraocular lens. Eur J Ophthalmol. 2014; 24(4): 501-508.

11. K. Gundersen. Diffractive multifocal IOLs: a comparative study of finevision versus ReSTOR 2.5 and 3.0D. Free Paper Session ESCRS 2014 London.

12. Raton, Alvaro Rodrigues. Update in intraocular lenses Dr. Alvaro R. Raton Lecture at Ovideo, EMYO 2016.